Omid Farokhzad Google Scholar: h-index, Total Citations, and Citation Map
Omid Farokhzad's h-index is 139 (263 i10-index, 109,398+ total citations across 479+ publications) according to Google Scholar as of October 2026. Omid Farokhzad is affiliated with CEO, Seer; (Previously Professor, Brigham & Women's Hospital and Harvard Medical School, USA).
Omid Farokhzad is a researcher affiliated with CEO, Seer; (Previously Professor, Brigham & Women's Hospital and Harvard Medical School, USA), specializing in Nanomedicine, Drug Delivery, Biomaterials. Their work has been cited 109,398 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Omid Farokhzad's Citation Metrics
Bibliometric impact based on 479 indexed publications.
- H-Index
- 139
- i10-Index
- 263
- Total Citations
- 109,398
- Citing Countries
- 20
As of October 2026.
Omid Farokhzad has an h-index of 139 and 109,398 total citations across 479 publications, with research cited by institutions in 20 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Omid Farokhzad's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Nanocarriers as an emerging platform for cancer therapy
202011,055
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher established nanocarriers as a foundational platform for cancer therapy, a seminal contribution evidenced by over 11,000 citations and widespread independent adoption.
The researcher established foundational insights into the factors governing the clearance and biodistribution of polymeric nanoparticles, a seminal contribution widely recognized in nanomedicine.
The researcher established a foundational framework for understanding the therapeutic applications and developmental trajectories of nanoparticles in medicine through a seminal 2008 publication.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Omid Farokhzad's research
Omid Farokhzad is a researcher in Nanomedicine, Drug Delivery and Biomaterials at CEO, Seer; (Previously Professor, Brigham & Women's Hospital and Harvard Medical School, USA). Their work has been cited 109,398 times across 479 publications (h-index 139), according to Google Scholar.
Their most-cited work, “Nanocarriers as an emerging platform for cancer therapy” (2020), has accumulated 11,055 citations. Other influential works include “Cancer nanomedicine: progress, challenges and opportunities” (2017) with 6,289 citations and “Factors affecting the clearance and biodistribution of polymeric nanoparticles” (2008) with 4,655 citations.
Citations of Omid Farokhzad's research come primarily from United States, China and India, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
